Hepatic endoderm differentiation from human embryonic stem cells

Current Stem Cell Research and Therapy

Volumn 5, Issue 3, 2010, Pages 233-244

  Hannoun, Zara ^a   Filippi, Céline ^a   Sullivan, Gareth ^a   Hay, David C ^a   Iredale, John P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Endoderm; Human embryonic stem cells; Hypoxia; Liver; Mitochondria

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR 1; ONCOSTATIN M; SCATTER FACTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; OXYGEN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDODERM; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPOXIA; LIVER CELL; LIVER DEVELOPMENT; MITOCHONDRION; OXYGEN TENSION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; ANOXIA; CELL ADHESION; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; LIVER; METABOLISM; METHODOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW;

ANIMALS; ANOXIA; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; ENDODERM; HEPATOCYTES; HUMANS; LIVER; MITOCHONDRIA; OXYGEN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 77957654689     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810791824403     Document Type: Article

References (169)

1. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5(10): 836-47. Review.
2. Burkhardt BR, Loiler SA, Anderson JA, et al. Glucose-responsive expression of the human insulin promoter in HepG2 human hepatoma cells. Ann N Y Acad Sci 2003; 1005: 237-41.
3. Rossi JM, Dunn NR, Hogan BL, Zaret KS. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 2001; 15(15): 1998-2009.
4. Zaret KS. Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet 2008; 9: 329-40.
5. Zhao R, Watt AJ, Li J, et al. GATA6 is essential for embryonic development of the liver but dispensable for early heart formation. Mol Cell Biol 2005; 25(7): 2622-3
6. Shin D, Shin CH, Tucker J, et al. Bmp and Fgf signaling are essential for liver specification in zebrafish. Development (Cambridge, England) 2007; 134: 2041-50.
7. Watt AJ, Zhao R, Li J and Duncan SA, Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Dev Biol 2007; 7: 37.
8. Calmont A, Wandzioch E, Tremblay KD, et al. An FGF response pathway that mediates hepatic gene induction in embryonic endoderm cells. Dev Cell 2006; 11: 339-48.
9. Jung J, Zheng M, Goldfarb M, Zaret KS. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science (New York, N.Y.) 1999; 284: 1998-2003.
10. Serls AE, Doherty S, Parvatiyar P, Wells JM, Deutsch GH. Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung. Development (Cambridge, England) 2005; 132: 35-47.
11. Huang H, Ruan H, Aw MY, et al. Mypt1-mediated spatial positioning of Bmp2-producing cells is essential for liver organogenesis. Development (Cambridge, England) 2008; 135: 3209-18.
12. McLin VA, Rankin SA, Zorn AM. Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development (Cambridge, England) 2007; 134: 2207-17.
13. Matsumoto K, Miki R, Nakayama M, Tatsumi N, Yokouchi Y. Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium. Dev Biol 2008; 319: 234-47.
14. Suksaweang S, Lin C-M, Jiang T-X, et al. Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation. Dev Biol 2004; 266: 109-22.
15. Ober EA, Verkade H, Field HA, Stainier DYR, Mesodermal Wnt2b Signaling positively regulates liver specification. Nature 2006; 442: 688-91.
16. Hay DC, Fletcher J, Payne C, et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci USA 2008; 105: 12301-6.
17. Nishina M, Kato T, Ito M, Takashima S. In vitro high resolution proton magnetic resonance study of human cerebellar development during the period from the fetus to childhood. Physiol Chem Phys Med NMR 1999; 31: 103-8.
18. Kamiya A, Kinoshita T, Miyajima A. Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. FEBS Lett 2001; 492: 90-4.
19. Tanaka M, Hara T, Copeland NG, et al. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Blood 1999; 93: 804-15.
20. Runge D, Runge DM, Drenning SD, et al. Growth and differentiation of rat hepatocytes: changes in transcription factors HNF-3, HNF-4, STAT-3, and STAT-5. Biochem Biophys Res Commun 1998; 250: 762-8.
21. Kamiya A, Kinoshita T, Ito Y, et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 1999; 18: 2127-36.
22. Kagoshima M, Kinoshita T, Matsumoto K, Nakamura T. Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung. Eur J Biochem/FEBS 1992; 210: 375-80.
23. Kinoshita T, Miyajima A. Cytokine regulation of liver development. Biochimica et biophysica acta 2002; 1592: 303-12.
24. Shiojiri N. Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech 1997; 39: 328-35.
25. Clotman F, Jacquemin P, Plumb-Rudewiez N, et al. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 2005; 19: 1849-54.
26. Weinstein M, Monga SP, Liu Y, et al. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development. Mol Cell Biol 2001; 21: 5122-31.
27. Ceccatelli S, Dagerlind A, Schalling M, et al. The glucocorticoid receptor in the adrenal gland is localized in the cytoplasm of adrenaline cells. Acta Physiol Scand 1989; 137: 559-60.
28. Eggert M, Möws CC, Tripier D, et al. A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J Biol Chem 1995; 270: 30755-9.
29. Bi Y, Huang J, He Y, et al. Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem 2009; 108(1): 295-303
30. Oh HY, Namkoong S, Lee SJ, et al. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP. Cell Death Differ 2006; 13: 512-23.
31. Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P, Vilarem MJ, Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 2000; 58: 1441-50.
32. Zelko I, Sueyoshi T, Kawamoto T, Moore R, Negishi M, The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol 2001; 21: 2838-46.
33. Trottier E, Belzil A, Stoltz C, Anderson A. Localization of a phenobarbital-responsive element (PBRE) in the 5'-flanking region of the rat CYP2B2 gene. Gene 1995; 158: 263-8.
34. Sidhu JS, Liu F, Omiecinski CJ. Phenoarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res 2004; 292: 252-64.
35. Gualdi R, Bossard P, Zheng M, et al. Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 1996; 10: 1670-82.
36. Bossard P, Zaret KS. GATA transcription factors as potentiators of gut endoderm differentiation. Development (Cambridge, England) 1998; 125: 4909-17.
37. Cirillo LA, Lin FR, Cuesta I, et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GA4. Mol Cell 2002; 9: 279-89.
38. Bort R, Zaret K. Paths to the pancreas. Nature genetics 2002; 32: 85-6.
39. Navas MA, Vaisse C, Boger S, et al. The human HNF-3 genes: cloning, partial sequence and mutation screening in patients with impaired glucose homeostasis. Hum Hered 2000; 50: 370-81.
40. Lokmane L, Haumaitre C, Garcia-Villalba P, et al. Crucial role of vHNF1 in vertebrate hepatic specification. Development (Cambridge, England) 2008; 135: 2777-86.
41. Charron F, Tsimiklis G, Arcand M, et al. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 2001; 15: 2702-19.
42. Dame C, Sola MC, Lim K-C, et al. Hepatic erythropoietin gene regulation by GATA-4. J Biol Chem 2004; 279: 2955-61.
43. Hattori H, Imai H, Kirai N, et al. Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancerbinding protein epsilon, for up-regulation of PHGPx in HL60 cells stimulated with TNF alpha. Biochem J 2007; 408: 277-86.
44. Limaye PB, Alarcón G, Walls AL, et al. Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Laboratory investigation. J Tech Methods Pathol 2008; 88: 865-72.
45. Coffinier C, Gresh L, Fiette L, et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development (Cambridge, England) 2002; 129: 1829-38.
46. Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003; 34: 292-6.
47. Dunn JC, Yarmush ML, Koebe HG, Tompkins RG, Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 1989; 3: 174-7.
48. Hughes RC, Stamatoglou SC, Adhesive interactions and the metabolic activity of hepatocytes. J Cell Sci Suppl 1987; 8: 273-91.
49. Moghe PV, Berthiaume F, Ezzell RM, et al. Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function. Biomaterials 1996; 17: 373-85.
50. Dalgetty DM, Medine CN, Iredale JP, Hay DC. Progress and Future Challenges in Stem Cell-Derived Liver Technologies. Am J Physiol Gastrointest Liver Physiol 2009; 297(2): G241-8.
51. Snykers S, De Kock J, Rogiers V, Vanhaecke T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 2008; 27(3): 577-605.
52. Rambhatla L, Chiu C-P, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transpl 2003; 12: 1-11.
53. Agarwal S, Holton KL, Lanza R, Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008; 26: 1117-27.
54. Schwartz RE, Linehan JL, Painschab MS, et al. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev 2005; 14: 643-55.
55. Shirahashi H, Wu J, Yamamoto N, et al. Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage. Cell Transpl 2004; 13: 197-211.
56. Kuai XL, Cong XQ, Li XL, Xiao SD. Generation of hepatocytes from cultured mouse embryonic stem cells. Liver Transpl 2003; 9: 1094-9.
57. Fletcher J, Cui W, Samuel K, et al. The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells 2008; 10: 331-9.
58. Hay DC, Zhao D, Fletcher J, et al. Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells (Dayton, Ohio) 2008; 26: 894-902.
59. Hay DC, Zhao D, Ross A, et al. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 2007; 9: 51-62.
60. Baharvand H, Hashemi SM, Kazemi Ashtiani S, Farrokhi A, Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 2006; 50: 645-52.
61. Du Y, Han R, Wen F, et al. Synthetic sandwich culture of 3D hepatocyte monolayer. Biomaterials 2008; 29: 290-301.
62. Yin C, Ying L, Zhang P-C, et al. High density of immobilized galactose ligand enhances hepatocyte attachment and function. J Biomed Mater Res A 2003; 67: 1093-104.
63. Lu H-F, Lim WS, Wang J, et al. Galactosylated PVDF membrane promotes hepatocyte attachment and functional maintenance. Biomaterials 2003; 24: 4893-903.
64. Basma H, Soto-Gutierrez A, Yannam GR, et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009; 136(3): 990-9.
65. Cai J, Zhao Y, Liu Y, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology (Baltimore, Md.) 2007; 45: 1229-39.
66. Baharvand H, Hashemi SM, Shahsavani M. Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. Differentiation 2008; 76: 465-77.
67. Pardal R, Ortega-Sáenz P, Durán R, López-Barneo J, Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell 2007; 131: 364-77.
68. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 2005; 102: 4783-8.
69. Covello KL, Kehler J, Yu H, et al. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006; 20: 557-70.
70. Lin Q, Kim Y, Alarcon RM, Yun Z, Oxygen and cell fate decisions. Gene Regulation and System Biology 2008; 2: 43-51.
71. Lin Q, Lee Y-J, Yun Z. Differentiation arrest by hypoxia. J Biol Chem 2006; 281: 30678-83.
72. Prasad SM, Czepiel M, Cetinkaya C, et al. Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation. Cell Prolif 2009; 42: 63-74.
73. Grayson WL, Zhao F, Bunnell B, Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007; 358: 948-53.
74. Dellatore SM, Garcia AS, Miller WM. Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol 2008; 19: 534-40.
75. Gustafsson MV, Zheng X, Pereira T, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9: 617-28.
76. Diez H, Fischer A, Winkler A, et al. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 2007; 313: 1-9.
77. Zheng X, Linke S, Dias JM, et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci USA 2008; 105: 3368-73.
78. Koay EJ, Athanasiou KA. Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality. Osteoarthritis Cartilage 2008; 16: 1450-6.
79. Zscharnack M, Poesel C, Galle J, Bader A. Low Oxygen Expansion Improves Subsequent Chondrogenesis of Ovine Bone-Marrow- Derived Mesenchymal Stem Cells in Collagen Type I Hydrogel Cells Tissues Organs 2009; 190(2): 81-93.
80. Michaylira CZ, Nakagawa H. Hypoxic microenvironment as a cradle for melanoma development and progression. Cancer Biol ther 2006; 5: 476-9.
81. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science (New York, N.Y.) 1998; 282: 1145-7.
82. Fischer B, Bavister BD. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil Suppl 1993; 99: 673-9.
83. Westfall SD, Sachdev S, Das P, et al. Identification of oxygensensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev 2008; 17: 869-81.
84. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-54.
85. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000; 88: 1474-80.
86. Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol 2009; 219: 271-5.
87. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, N.Y.) 2001; 292: 468-72.
88. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.
89. Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxiainducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2000; 2: 423-7.
90. Ghosh AK, Shanafelt TD, Cimmino A, et al. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009; 113(22): 5568-74.
91. Sandau KB, Fandrey J, Brüne B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 2001; 97: 1009-15.
92. Hellwig-Bürgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94: 1561-7.
93. Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 1999; 274: 33709-13.
94. Richard DE, Berra E, Gothié E, Roux D, Pouysségur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999; 274: 32631-7.
95. Zelzer E, Levy Y, Kahana C, et al. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF- 1alpha/ARNT. EMBOJ 1998; 17: 5085-94.
96. Feldser D, Agani F, Iyer NV, et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 1999; 59: 3915-8.
97. Carroll VA, Ashcroft M. Role of hypoxia-inducible factor (HIF)- 1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 2006; 66: 6264-70.
98. Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997; 57: 5328-35.
99. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 2000; 14: 34-44.
100. Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391-6.
101. Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH, Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 2006; 107: 2705-12.
102. Koshiji M, Kageyama Y, Pete EA, et al. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004; 23: 1949-56.
103. Bos R, van D, de J, van d. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005; 46: 31-6.
104. Koshiji M, Huang LE. Dynamic balancing of the dual nature of HIF-1alpha for cell survival. Cell Cycle 2004; 3: 853-4.
105. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997; 386: 403-7.
106. Pedersen M, Löfstedt T, Sun J, et al. Stem cell factor induces HIF- 1alpha at normoxia in hematopoietic cells. Biochem Biophys Res Commun 2008; 377: 98-103.
107. Patel SA, Simon MC. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 2008; 15: 628-34.
108. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002; 2: 331-41.
109. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124: 471-84.
110. Harada H, Itasaka S, Kizaka-Kondoh S, et al. The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucoseand reoxygenation-dependent manner in irradiated tumors. J Biol Chem 2009; 284: 5332-42.
111. Liu L, Wise DR, Diehl JA, Simon MC. Hypoxic reactive oxygen species regulate the integrated stress response and cell survival. J Biol Chem 2008; 283: 31153-62.
112. Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 2003; 278: 29655-60.
113. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005-15.
114. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12: 149-62.
115. Hu C-J, Wang L-Y, Chodosh LA, Keith B, Simon MC. Differential Roles of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in Hypoxic Gene Regulation. Mol Cell Biol 2003; 23: 9361-74.
116. Covello KL, Simon MC, Keith B. Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor- 2alpha knock-in allele promotes tumor growth. Cancer Res 2005; 65: 2277-86.
117. Klimova T, Chandel NS. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ 2008; 15: 660-66.
118. Ateghang B, Wartenberg M, Gassmann M, Sauer H. Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF- 1alpha and intracellular reactive oxygen species. J Cell Sci 2006; 119: 1043-52.
119. Sanjuán-Pla A, Cervera AM, Apostolova N, et al. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett 2005; 579: 2669-74.
120. Schieke SM, Ma M, Cao L, et al. Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J Biol Chem 2008; 283: 28506-12.
121. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009; 458(7239): 780-3.
122. Piccoli C, Ria R, Scrima R, et al. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J Biol Chem 2005; 280: 26467-76.
123. Studer L, Csete M, Lee SH, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 2000; 20(19): 7377-83.
124. Pistollato F, Chen H-L, Schwartz PH, Basso G, Panchision DM, Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 2007; 35: 424-35.
125. Milosevic J, Maisel M, Wegner F, et al. Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci 2007; 27: 412-21.
126. Niebruegge S, Bauwens CL, Peerani R, et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 2009; 102: 493-507.
127. Yun Z, Lin Q, Giaccia AJ. Adaptive myogenesis under hypoxia. Mol Cell Biol 2005; 25: 3040-55.
128. Inoki K, Ouyang H, Zhu T, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006; 126: 955-68.
129. Schumacker PT, Chandel N, Agusti AG. Oxygen conformance of cellular respiration in hepatocytes. Am J Physiol 1993; 265: L395-L402.
130. Görlach A, Kietzmann T, Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol 2007; 421-46.
131. Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria- ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.) 2009; 8: 1158-60.
132. Chen C, Liu Y, Liu R, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008; 205: 2397-408.
133. Wiesner RJ, Rüegg JC, Morano I. Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Commun 1992; 183: 553-9.
134. Bolender N, Sickmann A, Wagner R, Meisinger C, Pfanner N. Multiple pathways for sorting mitochondrial precursor proteins. EMBO Rep 2008; 9: 42-9.
135. Martínez-Diez M, Santamaría G, Ortega AD, Cuezva JM. Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs. PLoS ONE 2006; 1: e107.
136. Kim K, Lecordier A, Bowman LH. Both nuclear and mitochondrial cytochrome c oxidase mRNA levels increase dramatically during mouse postnatal development. Biochem J 1995; 306 (Pt 2): 353-8.
137. Lin JD. Minireview: the PGC-1 coactivator networks: chromatinremodeling and mitochondrial energy metabolism. Mol Endocrinol 2009; 23: 2-10.
138. McClure TD, Young ME, Taegtmeyer H, et al. Thyroid hormone interacts with PPARalpha and PGC-1 during mitochondrial maturation in sheep heart. Am J Physiol Heart Circ Physiol 2005; 289: H2258-64.
139. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochem Biophys Acta 2002; 1576: 1-14.
140. Scarpulla RC. Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 2006; 97: 673-83.
141. Cotney J, Wang Z, Shadel GS. Relative abundance of the human mitochondrial transcription system and distinct roles for h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene expression. Nucleic Acids Res 2007; 35: 4042-54.
142. Brenner CA, Kubisch HM, Pierce KE. Role of the mitochondrial genome in assisted reproductive technologies and embryonic stem cell-based therapeutic cloning. Reprod Fertil Dev 2004; 16: 743-51.
143. Müller-Höcker J, Schäfer S, Weis S, Münscher C, Strowitzki T. Morphological-cytochemical and molecular genetic analyses of mitochondria in isolated human oocytes in the reproductive age. Mol Hum Reprod 1996; 2: 951-8.
144. Van Blerkom J, Davis P, Alexander S. Differential mitochondrial distribution in human pronuclear embryos leads to disproportionate inheritance between blastomeres: relationship to microtubular organization, ATP content and competence. Hum Reprod (Oxford, England) 2000; 15: 2621-33.
145. Van Blerkom J, Cox H, Davis P. Regulatory roles for mitochondria in the peri-implantation mouse blastocyst: possible origins and developmental significance of differential DeltaPsim. Reproduction (Cambridge, England) 2006; 131: 961-76.
146. Manser RC, Leese HJ, Houghton FD. Effect of inhibiting nitric oxide production on mouse preimplantation embryo development and metabolism. Biol Reprod 2004; 71: 528-33.
147. Manser RC, Houghton FD. Ca2+ -linked upregulation and mitochondrial production of nitric oxide in the mouse preimplantation embryo. J Cell Sci 2006; 119: 2048-55.
148. Alcolea MP, Colom B, Lladó I, García-Palmer FJ and Gianotti M. Mitochondrial differentiation and oxidative phosphorylation system capacity in rat embryo during placentation period. Reproduction (Cambridge, England) 2007; 134: 147-54.
149. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ. Heart mitochondrial DNA and enzyme changes during early human development. Mol Cell Biochem 2000; 210: 47-52.
150. Izquierdo JM, Luis AM, Cuezva J. Postnatal mitochondrial differentiation in rat liver. Regulation by thyroid hormones of the beta-subunit of the mitochondrial F1-ATPase complex. J Biol Chem 1990; 265: 9090-7.
151. Prieur B, Cordeau-Lossouarn L, Rotig A, et al. Perinatal maturation of rat kidney mitochondria. Biochem J 1995; 305 (Pt 2): 675-80.
152. Nakai A, Taniuchi Y, Asakura H, et al. Developmental changes in mitochondrial activity and energy metabolism in fetal and neonatal rat brain. Brain Res Dev Brain Res 2000; 121(1): 67-72.
153. Minai L, Martinovic J, Chretien D, et al. Mitochondrial respiratory chain complex assembly and function during human fetal development. Molecular genetics and metabolism 2008; 94: 120-6.
154. Hale DE, Williamson JR. Developmental changes in the adenine nucleotide translocase in the guinea pig. J Biol Chem 1984; 259: 8737-42.
155. Valcarce C, Navarrete RM, Encabo P, et al. Postnatal development of rat liver mitochondrial functions. The roles of protein synthesis and of adenine nucleotides. J Biol Chem 1988; 263: 7767-75.
156. Valcarce C, Izquierdo JM, Chamorro M, Cuezva JM. Mammalian adaptation to extrauterine environment: mitochondrial functional impairment caused by prematurity. Biochem J 1994; 855-62.
157. Girard J. Metabolic adaptations to change of nutrition at birth. Biol Neonate 1990; 3-15.
158. Pegorier JP, Prip-Buus C, Duee PH, Girard J. Hormonal control of fatty acid oxidation during the neonatal period. Diabetes Metab 1992; 18: 156-60.
159. Sutton R, Pollak JK, Hormone-initiated maturation of rat liver mitochondria after birth. Biochem J 1980; 186: 361-7.
160. Pollak JK, Sutton R, The transport and accumulation of adenine nucleotides during mitochondrial biogenesis. Biochem J 1980; 192: 75-83.
161. Luis AM, Izquierdo JM, Ostronoff LK, et al. Translational regulation of mitochondrial differentiation in neonatal rat liver. Specific increase in the translational efficiency of the nuclearencoded mitochondrial beta-F1-ATPase mRNA. J Biol Chem 1993; 268: 1868-75.
162. Izquierdo JM, Cuezva JM. Control of the translational efficiency of beta-F1-ATPase mRNA depends on the regulation of a protein that binds the 3' untranslated region of the mRNA. Mol Cell Biol 1997; 17: 5255-68.
163. Ostronoff LK, Izquierdo JM, Enríquez JA, Montoya J, Cuezva JM. Transient activation of mitochondrial translation regulates the expression of the mitochondrial genome during mammalian mitochondrial differentiation. Biochem J 1996; 183-91.
164. Di Liegro CM, Bellafiore M, Izquierdo JM, Rantanen A, Cuezva JM. 3'-untranslated regions of oxidative phosphorylation mRNAs function in vivo as enhancers of translation. Biochem J 2000; 109-15.
165. Izquierdo JM, Cuezva JM. Epigenetic regulation of the binding activity of translation inhibitory proteins that bind the 3' untranslated region of beta-F1-ATPase mRNA by adenine nucleotides and the redox state. Arch Biochem Biophys 2005; 433(2): 481-6.
166. Li L, Shen JJ, Bournat JC, et al. Activin signaling: effects on body composition and mitochondrial energy metabolism. Endocrinology 2009; 150(8): 3521-9.
167. Meinhardt A, McFarlane JR, Seitz J, de Kretser DM. Activin maintains the condensed type of mitochondria in germ cells. Mol Cell Endocrinol 2000; 168: 111-7.
168. Vogel RO, Janssen RJ, van d, et al. Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly. Genes Dev 2007; 21: 615-24.
169. DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008; 22: 239-51.